medcalc version 22.0 (MedCalc Software Ltd)
90
Structured Review
MedCalc Software Ltd
medcalc version 22.0
Medcalc Version 22.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/medcalc+version+22%2E0/medcalc+9+0+1/pm40604558-86-3-7
Average 90 stars, based on 1 article reviews
Medcalc Version 22.0, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/medcalc+version+22%2E0/medcalc+9+0+1/pm40604558-86-3-7
Average 90 stars, based on 1 article reviews
medcalc version 22.0 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Spectral computed tomography parameters for predicting vessels encapsulating tumor clusters (VETC) pattern in hepatocellular carcinoma: a pilot study Article Snippet: All statistical analyses were performed using SPSS 23.0 (IBM Corp., Armonk, NY, USA), Article Title: Risk-adapted scoring model to identify candidates benefiting from adjuvant chemotherapy after radical nephroureterectomy for localized upper urinary tract urothelial carcinoma: A multicenter study Article Snippet: Statistical analysis was conducted using IBM SPSS Statistics version 27.0 (IBM Corp.), Article Title: PET/computed tomography radiomics combined with clinical features in predicting sarcopenia and prognosis of diffuse large B-cell lymphoma Article Snippet: Methods A total of 178 DLBCL patients (118 and 60 applied for training and test sets, respectively) who underwent pretreatment F-FDG PET/CT were retrospectively enrolled.. Clinical characteristics and PET/CT radiomics features were analyzed, and feature selection was performed using univariate logistic regression and correlation analysis.. Sarcopenia prediction models were built by ML algorithms and evaluated. Article Title: Celiac Disease and Liver Damage: The Gut–Liver Axis Strikes Back (Again)? A Retrospective Analysis in the Light of a Literature Review Article Snippet: IBM SPSS Statistics, version 27.0 software (IBM SPSS Inc., Chicago, IL, USA), and Article Title: Complement Activation and Hemolysis in Non-Human Primates Following Transfusion of Genetically Modified Pig Red Blood Cells. Article Snippet: Statistical analyses were conducted using Article Title: Reliability and validity analysis of the Chinese version of the Quick Dementia Rating System (QDRS). Article Snippet: SPSS (version 26.0), Article Title: Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort. Article Snippet: MASLD and Alcohol-Related Liver Diseases Diagnostic performance of non-invasive tests in patients with MetALD in a health check-up cohort Joo Hyun Oh1,†, Sang Bong Ahn1,†, Seon Cho2, Eun-Hee Nah2,3, Eileen L. Yoon4,5,*, Dae Won Jun4,5,* Journal of Hepatology 2024. vol.. 81 j 772–780 Background & Aims: Non-invasive tests (NITs) for liver fibrosis have been recognized for their clinical utility in metabolic dysfunction-associated steatotic liver disease (MASLD).. However, their diagnostic efficacy in detecting liver fibrosis is notably reduced in patients with alcohol-related liver disease. |